Cargando…

The failure of cetuximab-based de-intensified regimes for HPV-positive OPSCC: A radiobiologists perspective

Human Papillomavirus-positive oropharyngeal cancer is a rising tumor entity with unique characteristics and favorable prognosis. Because current multimodal therapies are associated with severe toxicity, different strategies for treatment de-intensification are being tested in clinical trials. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rieckmann, Thorsten, Kriegs, Malte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558227/ https://www.ncbi.nlm.nih.gov/pubmed/31206086 http://dx.doi.org/10.1016/j.ctro.2019.05.003

Ejemplares similares

Detection of HPV in oral rinse samples from OPSCC and non-OPSCC patients
por: Dang, Juliet, et al.
Publicado: (2015)

Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines
por: Busch, Chia-Jung, et al.
Publicado: (2016)

The molecular mechanisms of increased radiosensitivity of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC): an extensive review
por: Liu, Changxing, et al.
Publicado: (2018)

Accuracy of p16 IHC in Classifying HPV-Driven OPSCC in Different Populations
por: Gallus, Roberto, et al.
Publicado: (2023)

Prevalence of Transcriptionally Active HPV Infection in Tumor-Free Oropharyngeal Tissue of OPSCC-Patients
por: Guarda, Vittoria, et al.
Publicado: (2022)

Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer
por: Wurlitzer, Marcus, et al.
Publicado: (2020)

Comprehensive Analysis of VEGFR2 Expression in HPV-Positive and -Negative OPSCC Reveals Differing VEGFR2 Expression Patterns
por: Uzun, Senem, et al.
Publicado: (2021)

Dual Inhibition of PARP and the Intra-S/G2 Cell Cycle Checkpoints Results in Highly Effective Radiosensitization of HPV-Positive HNSCC Cells
por: Hintelmann, Katharina, et al.
Publicado: (2021)

Correlation of HPV16 Gene Status and Gene Expression With Antibody Seropositivity and TIL Status in OPSCC
por: von Witzleben, Adrian, et al.
Publicado: (2021)

The Impact of Human Papillomavirus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) on Nutritional Outcomes
por: Harrowfield, Jane, et al.
Publicado: (2021)

Improving the Efficacy of Tumor Radiosensitization Through Combined Molecular Targeting
por: Hintelmann, Katharina, et al.
Publicado: (2020)

Human papillomavirus (HPV) in Chinese oropharyngeal squamous cell carcinoma (OPSCC): A strong predilection for the tonsil
por: Xu, Tingting, et al.
Publicado: (2020)

A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease?
por: Balk, Matthias, et al.
Publicado: (2023)

Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium
por: Kreimer, A R, et al.
Publicado: (2019)

A Lack of Effectiveness in the ATM-Orchestrated DNA Damage Response Contributes to the DNA Repair Defect of HPV-Positive Head and Neck Cancer Cells
por: Köcher, Sabrina, et al.
Publicado: (2022)

Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study)
por: Oliva, Marc, et al.
Publicado: (2021)

HPV sensitizes OPSCC cells to cisplatin-induced apoptosis by inhibiting autophagy through E7-mediated degradation of AMBRA1
por: Antonioli, Manuela, et al.
Publicado: (2020)

Locally advanced high-risk HPV related oropharyngeal squamous cell carcinoma (OPSCC); have we forgotten it is a different disease?
por: Saba, Nabil F, et al.
Publicado: (2018)

p16, HPV, and Cetuximab: What Is the Evidence?
por: Bonner, James A., et al.
Publicado: (2017)

Physician perspectives on de-intensifying diabetes medications
por: Genere, Natalia, et al.
Publicado: (2016)

Impaired DNA double-strand break repair and effective radiosensitization of HPV-negative HNSCC cell lines through combined inhibition of PARP and Wee1
por: Oetting, Agnes, et al.
Publicado: (2023)

The dogma of Cetuximab and Radiotherapy in head and neck cancer – A dawn to dusk journey
por: Krishnamurthy, Sapna, et al.
Publicado: (2022)

Heterotypic neutrophil-in-tumor structure: A novel pathological feature first discovered in the tissues of OPSCC
por: Fan, Jie, et al.
Publicado: (2022)

Cetuximab intensifies the ADCC activity of adoptive NK cells in a nude mouse colorectal cancer xenograft model
por: Chen, Shanshan, et al.
Publicado: (2016)

Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial
por: Jones, David A., et al.
Publicado: (2020)

Evaluating contralateral neck failure in patients with lateralized OPSCC treated with transoral robotic surgery and neck management based on pre-operative SPECT-CT lymphatic mapping
por: Berania, Ilyes, et al.
Publicado: (2022)

Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2022)

G2 checkpoint targeting via Wee1 inhibition radiosensitizes EGFRvIII-positive glioblastoma cells
por: Cetin, Meryem H., et al.
Publicado: (2023)

Preservation of swallowing function with de-intensified chemoradiation therapy for HPV-associated oropharyngeal squamous cell carcinoma
por: Judy, Greg D., et al.
Publicado: (2018)

Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma
por: Braig, Friederike, et al.
Publicado: (2016)

Newly detected DNA viruses in juvenile nasopharyngeal angiofibroma (JNA) and oral and oropharyngeal squamous cell carcinoma (OSCC/OPSCC)
por: Dickinson, Amy, et al.
Publicado: (2018)

Coronavirus disease 19 (COVID-19) during chemoradiation for locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC)
por: Denaro, Nerina, et al.
Publicado: (2020)

Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer
por: Braig, Friederike, et al.
Publicado: (2015)

EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells
por: Struve, Nina, et al.
Publicado: (2015)

Assessing the performance of a Loop Mediated Isothermal Amplification (LAMP) assay for the detection and subtyping of high-risk suptypes of Human Papilloma Virus (HPV) for Oropharyngeal Squamous Cell Carcinoma (OPSCC) without DNA purification
por: Rohatensky, Mitchell G., et al.
Publicado: (2018)

Prognostic prediction models for oropharyngeal squamous cell carcinoma (OPSCC): a protocol for systematic review, critical appraisal and meta-analysis
por: Lu, Zhen, et al.
Publicado: (2023)

Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status
por: Baysal, Hasan, et al.
Publicado: (2020)

Roscovitine strongly enhances the effect of olaparib on radiosensitivity for HPV neg. but not for HPV pos. HNSCC cell lines
por: Ziemann, Frank, et al.
Publicado: (2017)

Radiosensitization of HNSCC cells by EGFR inhibition depends on the induction of cell cycle arrests
por: Kriegs, Malte, et al.
Publicado: (2016)

Cost- effectiveness of HPV vaccination regime: comparing twice versus thrice vaccinations dose regime among adolescent girls in Malaysia
por: Aljunid, Syed, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g2rr54errraiaimp46tffujr65